Pharmacokinetics of flurbiprofen

Area of Science:

• Pharmacology
• Drug Metabolism
• Clinical Pharmacokinetics

Background:

• Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation.
• Understanding its pharmacokinetic profile is crucial for optimizing therapeutic efficacy and safety.

Purpose of the Study:

• To investigate the pharmacokinetics of flurbiprofen using both radiolabeled and nonlabeled drug.
• To assess the impact of oral dose and formulation on drug absorption, disposition, and bioavailability.
• To determine if long-term flurbiprofen administration affects its own metabolism.

Main Methods:

• Pharmacokinetic studies utilizing radiolabeled and nonlabeled flurbiprofen.
• Analysis of plasma drug concentrations over time following single and multiple oral doses.
• Evaluation of drug absorption, elimination half-life, and area under the plasma concentration-time curve (AUC).

Main Results:

• Flurbiprofen exhibits rapid absorption and a dose-independent elimination half-life.
• The area under the plasma concentration-time curve (AUC) increases proportionally with the oral dose.
• Elimination of intact flurbiprofen from circulation is biphasic and rapid.
• Equivalent bioavailability was observed for 100 mg flurbiprofen administered as four 25-mg, two 50-mg, or one 100-mg tablet.
• Long-term flurbiprofen administration did not appear to inhibit or induce its metabolism.

Conclusions:

• Flurbiprofen's pharmacokinetic profile is characterized by rapid absorption and predictable dose proportionality.
• Different oral dosage regimens of flurbiprofen yield comparable bioavailability.
• The drug's metabolism remains stable even with chronic administration, suggesting a low risk of auto-induction or inhibition.